Company / Current Liabilities per Share
Gain Therapeutics, Inc. Current Liabilities per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.24
FY2024
5-year range
$0.24 / $0.72
FY2021-FY2024
Trend
-42.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.35 to $0.24 over the past 2 years.
Based on SEC 10-K filings.
0.24 in FY2024 with a 3-year CAGR of -30.5%.
Improved from $0.35 to $0.24 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -30.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 42.1% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -16.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.24 | -42.1% |
| FY2023 | $0.42 | +20.0% |
| FY2022 | $0.35 | -51.8% |
| FY2021 | $0.72 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026